LykeShares
Chat Trending Shares
Sign up
Login
Sign Up
(current)
Top 10 Trends
Watchlist
Feedback
Advertise With Us
Profile
Home
Search
Top 10 Trends
Watchlist
Advertise
Feedback
Profile
Collegium Pharmaceutical Inc. Chat
+
Link
Image
Poll
A
Lykeshares
2y
Official
$IXR
How Many Shares Ionic Rare Earths Directors Hold?
567 Views
1 Like
Reply
S
Lykeshares
2y
Official
$BML
Who is Simon Noon? CEO of Boab Metals
368 Views
1 Like
Reply
M
Lykeshares
2y
Official
$NVA
Why are the Tomahawk and Trundle discoveries significant for Nova Minerals?
426 Views
1 Like
Reply
G
Lykeshares
2y
Official
$HUT
How does the acquisition impact Hut 8's position in Digital Mining?
494 Views
1 Like
Reply
D
Lykeshares
2y
Official
$QPM
How did Queensland Pacific Metals achieve 5N purity in HPA?
451 Views
1 Like
Reply
F
Lykeshares
2y
Official
$AUZ
Why has Australian Mines chosen Brazil for its exploration projects?
399 Views
1 Like
Reply
C
Lykeshares
2y
Official
$ADO
How Many Shares Anteotech Directors Hold?
749 Views
1 Like
Reply
C
Lykeshares
2y
Official
$VMM
How Many Shares Viridis Mining Directors Hold?
438 Views
1 Like
Reply
S
Lykeshares
2y
Official
$PMT
Deep Dive on Patriot Battery Metals from their Quarterly
547 Views
1 Like
Reply
M
Lykeshares
2y
Official
$DLI
What are Delta Lithium's drilling results from Yinnetharra and Mt Ida projects?
422 Views
1 Like
Reply
C
Lykeshares
2y
Official
$VMM
Why did Viridis choose Hatch for the Colossus Project's scoping study?
437 Views
1 Like
Reply
T
Lykeshares
2y
Official
$ADO
How does AnteoTech Plan to Expand its Production at the Brisbane facility?
470 Views
1 Like
Reply
A
Lykeshares
2y
Official
$SYA
Who is Lucas Dow? The New Director Appointment to the Sayona Board
574 Views
1 Like
Reply
S
Lykeshares
2y
Official
$MNS
How is Magnis planning to refinance iM3NY's $100M USD credit facility?
639 Views
1 Like
Reply
M
Lykeshares
2y
Official
$PNRL
Who is Jim Gowans? Chairman of Premium Nickel Resources
736 Views
1 Like
Reply
Loading…
NASDAQ:COLL — Live Chart, Financials & Chat | Collegium Pharmaceutical Inc.
C
Collegium Pharmaceutical Inc.
NASDAQ:COLL
United States
Revenue: 707m
$0.0/sec
Add to Watchlist
by TradingView